科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2016/11/15 | 6,220 | 6,290 | 6,150 | 6,190 | -50 | -0.8% | 192,000 |
| 2016/11/14 | 6,200 | 6,280 | 6,170 | 6,240 | +80 | +1.3% | 154,400 |
| 2016/11/11 | 6,080 | 6,180 | 6,060 | 6,160 | +170 | +2.8% | 354,500 |
| 2016/11/10 | 6,110 | 6,110 | 5,900 | 5,990 | +190 | +3.3% | 293,200 |
| 2016/11/09 | 5,910 | 6,020 | 5,680 | 5,800 | -90 | -1.5% | 364,900 |
| 2016/11/08 | 6,170 | 6,200 | 5,850 | 5,890 | -480 | -7.5% | 397,900 |
| 2016/11/07 | 6,270 | 6,480 | 6,140 | 6,370 | +190 | +3.1% | 321,500 |
| 2016/11/04 | 6,290 | 6,290 | 6,130 | 6,180 | -230 | -3.6% | 257,900 |
| 2016/11/02 | 6,540 | 6,540 | 6,370 | 6,410 | -170 | -2.6% | 146,300 |
| 2016/11/01 | 6,550 | 6,600 | 6,510 | 6,580 | -40 | -0.6% | 119,300 |
| 2016/10/31 | 6,560 | 6,630 | 6,530 | 6,620 | -40 | -0.6% | 171,000 |
| 2016/10/28 | 6,650 | 6,710 | 6,620 | 6,660 | +50 | +0.8% | 403,800 |
| 2016/10/27 | 6,560 | 6,630 | 6,540 | 6,610 | +20 | +0.3% | 116,100 |
| 2016/10/26 | 6,490 | 6,590 | 6,480 | 6,590 | +60 | +0.9% | 117,500 |
| 2016/10/25 | 6,490 | 6,540 | 6,470 | 6,530 | +50 | +0.8% | 100,900 |
| 2016/10/24 | 6,480 | 6,500 | 6,430 | 6,480 | -20 | -0.3% | 114,500 |
| 2016/10/21 | 6,450 | 6,500 | 6,430 | 6,500 | +40 | +0.6% | 129,100 |
| 2016/10/20 | 6,440 | 6,490 | 6,410 | 6,460 | -10 | -0.2% | 160,300 |
| 2016/10/19 | 6,400 | 6,500 | 6,400 | 6,470 | +100 | +1.6% | 150,600 |
| 2016/10/18 | 6,240 | 6,390 | 6,240 | 6,370 | +90 | +1.4% | 141,800 |
| 2016/10/17 | 6,310 | 6,360 | 6,260 | 6,280 | -60 | -0.9% | 141,800 |
| 2016/10/14 | 6,390 | 6,430 | 6,320 | 6,340 | -80 | -1.2% | 143,000 |
| 2016/10/13 | 6,370 | 6,460 | 6,360 | 6,420 | +60 | +0.9% | 138,900 |
| 2016/10/12 | 6,320 | 6,430 | 6,320 | 6,360 | -70 | -1.1% | 154,300 |
| 2016/10/11 | 6,350 | 6,460 | 6,350 | 6,430 | +90 | +1.4% | 100,700 |
| 2016/10/07 | 6,360 | 6,400 | 6,320 | 6,340 | -60 | -0.9% | 124,800 |
| 2016/10/06 | 6,390 | 6,420 | 6,350 | 6,400 | +40 | +0.6% | 141,200 |
| 2016/10/05 | 6,390 | 6,400 | 6,320 | 6,360 | +30 | +0.5% | 114,700 |
| 2016/10/04 | 6,320 | 6,370 | 6,300 | 6,330 | +40 | +0.6% | 147,800 |
| 2016/10/03 | 6,230 | 6,330 | 6,200 | 6,290 | +110 | +1.8% | 141,200 |
| 2016/09/30 | 6,210 | 6,270 | 6,120 | 6,180 | -160 | -2.5% | 154,100 |
| 2016/09/29 | 6,390 | 6,400 | 6,310 | 6,340 | +50 | +0.8% | 185,300 |
| 2016/09/28 | 6,330 | 6,330 | 6,210 | 6,290 | -120 | -1.9% | 170,400 |
| 2016/09/27 | 6,250 | 6,410 | 6,190 | 6,410 | +30 | +0.5% | 157,300 |
| 2016/09/26 | 6,390 | 6,460 | 6,330 | 6,380 | -30 | -0.5% | 117,300 |
| 2016/09/23 | 6,320 | 6,430 | 6,250 | 6,410 | +110 | +1.7% | 193,300 |
| 2016/09/21 | 6,030 | 6,300 | 6,020 | 6,300 | +270 | +4.5% | 167,200 |
| 2016/09/20 | 6,080 | 6,150 | 6,010 | 6,030 | -110 | -1.8% | 140,700 |
| 2016/09/16 | 6,030 | 6,160 | 6,010 | 6,140 | +150 | +2.5% | 128,700 |
| 2016/09/15 | 5,910 | 6,010 | 5,910 | 5,990 | +70 | +1.2% | 122,500 |
| 2016/09/14 | 5,970 | 5,980 | 5,910 | 5,920 | -70 | -1.2% | 111,700 |
| 2016/09/13 | 5,970 | 6,020 | 5,940 | 5,990 | +120 | +2% | 114,200 |
| 2016/09/12 | 5,880 | 5,960 | 5,860 | 5,870 | -70 | -1.2% | 134,900 |
| 2016/09/09 | 6,050 | 6,060 | 5,930 | 5,940 | -110 | -1.8% | 127,300 |
| 2016/09/08 | 5,950 | 6,060 | 5,910 | 6,050 | +110 | +1.9% | 163,900 |
| 2016/09/07 | 5,940 | 6,020 | 5,930 | 5,940 | ±0 | ±0% | 147,600 |
| 2016/09/06 | 5,840 | 5,960 | 5,820 | 5,940 | +100 | +1.7% | 128,200 |
| 2016/09/05 | 6,050 | 6,080 | 5,820 | 5,840 | -190 | -3.2% | 192,900 |
| 2016/09/02 | 5,950 | 6,040 | 5,950 | 6,030 | +90 | +1.5% | 103,600 |
| 2016/09/01 | 5,850 | 5,970 | 5,820 | 5,940 | +100 | +1.7% | 135,100 |
2101～
2150
件表示中 / 3725件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 384,400円 | -6.4% | -71.8% | 4.94% | 42.94倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 376,500円 | +21.7% | +999.9% | 0.00% | 15.77倍 | 5.22倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| 東和薬品 | 295,300円 | +7.9% | -3.3% | 2.71% | 8.21倍 | 0.85倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 204,800円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
